Literature DB >> 31949657

MicroRNA-20a-5p inhibits epithelial to mesenchymal transition and invasion of endometrial cancer cells by targeting STAT3.

Yu Huang1, Nian Yang1.   

Abstract

BACKGROUND: Endometrial cancer (EC) is the fourth most common malignancy among women. Epithelial to mesenchymal transition (EMT) and invasion have been identified as central cellular processes in tumor progression and malignant transformation. The function and molecular basis of microRNA-20a-5p (miR-20a-5p) in the development of EC are poorly defined.
METHODS: RT-qPCR assay was used to detect the levels of miR-20a-5p and signal transducer and activator of transcription 3 (STAT3) mRNA. Western blot assay was conducted to determine protein expression of STAT3, N-cadherin, Vimentin and E-cadherin. Cell invasive capacity was examined by transwell invasion assay. Bioinformatics analysis, luciferase reporter assay and RIP assay were performed to investigate the interaction between miR-20a-5p and STAT3 3'UTR.
RESULTS: miR-20a-5p expression was strikingly reduced in EC tissues and cells. Functional analysis revealed that miR-20a-5p overexpression inhibited EMT and invasion of EC cells. Further exploration showed that miR-20a-5p inhibited STAT3 expression by direct interaction. Moreover, the knockdown of STAT3 suppressed EMT and invasion of EC cells. Additionally, the depletion of STAT3 weakened miR-20a-5p downregulation-induced cell EMT and invasion in EC.
CONCLUSION: miR-20a-5p inhibited EMT and invasion of EC cells by targeting STAT3, highlighting the vital roles of miR-20a-5p and STAT3 in the metastasis and malignant transformation of EC. IJCEP
Copyright © 2018.

Entities:  

Keywords:  STAT3; endometrial cancer; epithelial to mesenchymal transition; invasion; microRNA-20a-5p

Year:  2018        PMID: 31949657      PMCID: PMC6963080     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  33 in total

1.  Tumorigenicity of the miR-17-92 cluster distilled.

Authors:  Gijs van Haaften; Reuven Agami
Journal:  Genes Dev       Date:  2010-01-01       Impact factor: 11.361

Review 2.  The role of microRNAs in the pathogenesis of endometrial cancer: a systematic review.

Authors:  Argiri Sianou; George Galyfos; Dimitra Moragianni; Panagiotis Andromidas; Georgios Kaparos; Stavroula Baka; Evangelia Kouskouni
Journal:  Arch Gynecol Obstet       Date:  2015-02-20       Impact factor: 2.344

3.  MicroRNA-20a-5p targets RUNX3 to regulate proliferation and migration of human hepatocellular cancer cells.

Authors:  Yanke Chen; Xiaofei Wang; Jiwen Cheng; Zhen Wang; Ting Jiang; Ni Hou; Na Liu; Tusheng Song; Chen Huang
Journal:  Oncol Rep       Date:  2016-10-04       Impact factor: 3.906

Review 4.  Endometrial cancer.

Authors:  Philippe Morice; Alexandra Leary; Carien Creutzberg; Nadeem Abu-Rustum; Emile Darai
Journal:  Lancet       Date:  2015-09-06       Impact factor: 79.321

Review 5.  miRiad roles for the miR-17-92 cluster in development and disease.

Authors:  Joshua T Mendell
Journal:  Cell       Date:  2008-04-18       Impact factor: 41.582

6.  Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target.

Authors:  Uksha Saini; Shan Naidu; Adam C ElNaggar; Hemant Kumar Bid; John J Wallbillich; Kristin Bixel; Chelsea Bolyard; Adrian A Suarez; Balveen Kaur; Periannan Kuppusamy; John Hays; Paul J Goodfellow; David E Cohn; Karuppaiyah Selvendiran
Journal:  Oncogene       Date:  2016-06-13       Impact factor: 9.867

7.  STAT3 regulated ARF expression suppresses prostate cancer metastasis.

Authors:  Jan Pencik; Michaela Schlederer; Wolfgang Gruber; Christine Unger; Steven M Walker; Athena Chalaris; Isabelle J Marié; Melanie R Hassler; Tahereh Javaheri; Osman Aksoy; Jaine K Blayney; Nicole Prutsch; Anna Skucha; Merima Herac; Oliver H Krämer; Peter Mazal; Florian Grebien; Gerda Egger; Valeria Poli; Wolfgang Mikulits; Robert Eferl; Harald Esterbauer; Richard Kennedy; Falko Fend; Marcus Scharpf; Martin Braun; Sven Perner; David E Levy; Tim Malcolm; Suzanne D Turner; Andrea Haitel; Martin Susani; Ali Moazzami; Stefan Rose-John; Fritz Aberger; Olaf Merkel; Richard Moriggl; Zoran Culig; Helmut Dolznig; Lukas Kenner
Journal:  Nat Commun       Date:  2015-07-22       Impact factor: 14.919

Review 8.  The Regulatory Role of MicroRNAs in EMT and Cancer.

Authors:  Apostolos Zaravinos
Journal:  J Oncol       Date:  2015-03-25       Impact factor: 4.375

9.  In vitro and in vivo activity of miR-92a-Locked Nucleic Acid (LNA)-Inhibitor against endometrial cancer.

Authors:  Anna Torres; Joanna Kozak; Agnieszka Korolczuk; Paulina Wdowiak; Ewa Domańska-Glonek; Ryszard Maciejewski; Kamil Torres
Journal:  BMC Cancer       Date:  2016-10-26       Impact factor: 4.430

10.  LncRNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR-20a-5p/HMGA2 axis in breast cancer.

Authors:  Wenyan Zhao; Donghua Geng; Shuqiang Li; Zhaofu Chen; Ming Sun
Journal:  Cancer Med       Date:  2018-02-23       Impact factor: 4.452

View more
  7 in total

Review 1.  Regulatory mechanism of miR-20a-5p expression in Cancer.

Authors:  Wei Huang; Xiaoyue Wu; Shuaixi Xiang; Mingxin Qiao; Xiao Cen; Xuefeng Pan; Xinqi Huang; Zhihe Zhao
Journal:  Cell Death Discov       Date:  2022-05-16

2.  Circulating microRNA Panel as a Potential Novel Biomarker for Oral Squamous Cell Carcinoma Diagnosis.

Authors:  Kodai Nakamura; Naomi Hiyake; Tomofumi Hamada; Seiya Yokoyama; Kazuki Mori; Kouta Yamashiro; Mahiro Beppu; Yasuaki Sagara; Yoshiaki Sagara; Tsuyoshi Sugiura
Journal:  Cancers (Basel)       Date:  2021-01-25       Impact factor: 6.639

3.  circRNA LDLRAD3 Enhances the Malignant Behaviors of NSCLC Cells via the miR-20a-5p-SLC7A5 Axis Activating the mTORC1 Signaling Pathway.

Authors:  Yu Li; Guangle Qin; Jinyun Du; Peng Yue; Yanling Zhang; Na Hou
Journal:  J Healthc Eng       Date:  2022-01-06       Impact factor: 2.682

Review 4.  MiRNAs: A Powerful Tool in Deciphering Gynecological Malignancies.

Authors:  Florentina Duică; Carmen Elena Condrat; Cezara Alina Dănila; Andreea Elena Boboc; Mihaela Raluca Radu; Junjie Xiao; Xinli Li; Sanda Maria Creţoiu; Nicolae Suciu; Dragoş Creţoiu; Dragoş-Valentin Predescu
Journal:  Front Oncol       Date:  2020-10-23       Impact factor: 6.244

5.  Serum miRNAs associated with tumor-promoting cytokines in non-small cell lung cancer.

Authors:  Pichitpon Chaniad; Keson Trakunran; Sarayut Lucien Geater; Warangkana Keeratichananont; Paramee Thongsuksai; Pritsana Raungrut
Journal:  PLoS One       Date:  2020-10-30       Impact factor: 3.240

Review 6.  MicroRNA as Epigenetic Modifiers in Endometrial Cancer: A Systematic Review.

Authors:  Amélia Favier; Grégoire Rocher; Annette K Larsen; Romain Delangle; Catherine Uzan; Michèle Sabbah; Mathieu Castela; Alex Duval; Céline Mehats; Geoffroy Canlorbe
Journal:  Cancers (Basel)       Date:  2021-03-06       Impact factor: 6.639

7.  Construction and analysis of a ceRNA network and patterns of immune infiltration in bladder cancer.

Authors:  Yang Fu; Shanshan Sun; Jianbin Bi; Chuize Kong; Lei Yin
Journal:  Transl Androl Urol       Date:  2021-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.